Cargando…
EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256479/ http://dx.doi.org/10.1016/j.jval.2023.03.541 |
| _version_ | 1785057112588550144 |
|---|---|
| author | Chacon-Araya, M. Ortendahl, J.D. Lee, J. Broder, M. Brusky, S. |
| author_facet | Chacon-Araya, M. Ortendahl, J.D. Lee, J. Broder, M. Brusky, S. |
| author_sort | Chacon-Araya, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10256479 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102564792023-06-12 EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission Chacon-Araya, M. Ortendahl, J.D. Lee, J. Broder, M. Brusky, S. Value Health Article Elsevier 2023-06 2023-06-10 /pmc/articles/PMC10256479/ http://dx.doi.org/10.1016/j.jval.2023.03.541 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Chacon-Araya, M. Ortendahl, J.D. Lee, J. Broder, M. Brusky, S. EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission |
| title | EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission |
| title_full | EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission |
| title_fullStr | EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission |
| title_full_unstemmed | EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission |
| title_short | EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission |
| title_sort | ee240 beyond symptoms alleviation: population-level benefits of covid-19 oral direct-acting antiviral (daa) treatment and resulting decreases in infectivity and transmission |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256479/ http://dx.doi.org/10.1016/j.jval.2023.03.541 |
| work_keys_str_mv | AT chaconarayam ee240beyondsymptomsalleviationpopulationlevelbenefitsofcovid19oraldirectactingantiviraldaatreatmentandresultingdecreasesininfectivityandtransmission AT ortendahljd ee240beyondsymptomsalleviationpopulationlevelbenefitsofcovid19oraldirectactingantiviraldaatreatmentandresultingdecreasesininfectivityandtransmission AT leej ee240beyondsymptomsalleviationpopulationlevelbenefitsofcovid19oraldirectactingantiviraldaatreatmentandresultingdecreasesininfectivityandtransmission AT broderm ee240beyondsymptomsalleviationpopulationlevelbenefitsofcovid19oraldirectactingantiviraldaatreatmentandresultingdecreasesininfectivityandtransmission AT bruskys ee240beyondsymptomsalleviationpopulationlevelbenefitsofcovid19oraldirectactingantiviraldaatreatmentandresultingdecreasesininfectivityandtransmission |